Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lamisil

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
In a randomized, double‐blind, double‐placebo, multicentre study, terbinafine 250 mg daily for 12 weeks was compared with… Expand
Highly Cited
2000
Highly Cited
2000
A method using liquid chromatography/tandem mass spectrometry (LC/MS/MS) for the determination of terbinafine in human and… Expand
1997
1997
Pityriasis versicolor is a chronic superficial fungal disease usually located on the upper trunk, neck or upper arms. Terbinafine… Expand
Highly Cited
1996
Highly Cited
1996
Several studies indicate that Pityrosporum ovale plays an important role in seborrhoeic dermatitis. Many of these are treatment… Expand
1995
1995
The antimycotic agent terbinafine (Lamisil) and five of its main metabolites were determined simultaneously in human plasma and… Expand
Highly Cited
1990
Highly Cited
1990
Lamid is a new antifungal drug which can be administered orrally and is effective against a broad range of dermatomycoses. This… Expand
1990
1990
The pharmacokinetics of terbinafine (Lamisil) have been studied in humans using both unlabelled and radiolabelled drug. Lamisil… Expand
Review
1989
Review
1989
  • J. C. Jensen
  • Clinical and experimental dermatology
  • 1989
  • Corpus ID: 31006428
Numerous studies have heen performed to describe the absorption, distribution, metabolism and excretion of terbinafine in healthy… Expand
Highly Cited
1989
Highly Cited
1989
Terbinafine (Lamisil) is the newest compound within a class of antimycotic drugs called allylamines. It is active against a broad… Expand
Highly Cited
1989
Highly Cited
1989
  • R. Savin
  • Clinical and experimental dermatology
  • 1989
  • Corpus ID: 25946890
Terbinafine (Lamisil) is the first safe and effective orally active agent in a new family of antifungal drugs, the allylamines… Expand